Market Place
Sourcing Support
MSN Lab`s Generic Carmustine Receives Receives Approval in the U.S.
11 May 2023 //
FDA
Accord`s Generic Carmustine Receives Approval in the U.S.
27 Dec 2022 //
FDA
Ingenus Pharma`s Generic Naloxone Hydrochloride Receives Approval in US
21 Jun 2022 //
FDA
Dr. Reddy`s Laboratories Launches Carmustine for Injection, USP in U.S. Market
15 Oct 2021 //
BUSINESSWIRE
Hong Kong BioPharma`s Generic Carmustine Receives Tentative Approval In US
02 Aug 2021 //
FDA
Jiangsu Hengrui’s Generic Carmustine Receives Approval In US
17 Mar 2021 //
FDA
STI Pharmaceuticals Generic Carmustine Receives Approval in US
05 Apr 2019 //
FDA
Amneal Wins First Priority Review ANDA Approval
31 Oct 2018 //
RAPS
Amneal Pharms`s Generic Carmustine Receives Approval in US
19 Oct 2018 //
FDA
Navinta LLC`s Generic Carmustine Receives Approval in US
14 Sep 2018 //
FDA
Bomaby High Court denies promoters of Taj Pharmaceuticals anticipatory bail
05 Dec 2016 //
ECONOMIC TIMES
Heritage Pharmaceuticals Issues Product Safety Warning
29 Apr 2016 //
PR NEWS WIRE
Anvisa approves novel medicines for asthma, hypertension and brain tumor
05 Oct 2015 //
ANVISA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.